Neste trabalho foram avaliados os efeitos da adição de polímeros precursores na sinterização, microestrutura, dureza e na tenacidade à natura de materiais cerâmicos à base de carbeto de silício e de AI2O3. As matérias-primas cerâmicas foram caracterizadas por análise semi-quantitativa por espectrometria de fluorescência de raios X, difração por laser, adsorção gasosa e microscopia eletrônica de varredura. Para os polímeros utilizou-se análise termogravimétrica. A cinética de sinterização das amostras compactadas foi estudada por dilatometria. A caracterização dos materiais sinterizados incluiu medidas de densidade aparente pelo princípio de Arquimedes e/ou por picnometria de He, porosimetria por intrusão de Hg, análises de difração de raios X, de carbono total, avaliação da microestrutura e por microscopia eletrônica de varredura e de transmissão, análise por espectrometria de raios X por dispersão de energia, ensaios de impressão Vickers para determinação de dureza e tenacidade à fiatura. No estudo de cerâmica à base de carbeto de silício foram utilizados os aditivos óxidos AI2O3 (4% em peso) e Y2O3 (4% em peso) e os aditivos poliméricos PMHS (polimetilhidrogenossiloxano) e polimetilhidrogenossiloxano com D4Vi. O processamento envolveu a cura do material, pirólise e sinterização (1850 °C e 1950 °C/l h. Ar ou N2). Nas amostras à base de carbeto de silício houve elevada perda de massa, principalmente quando a atmosfera de sinterização foi argônio. As amostras à base de carbeto de silício, com adição de polímeros atingiram densidade de até 3,15 g/cm3 quando pirolisadas a 900 °C em N2 e sinterizadas a 1950 °C, em atmosfera de nitrogênio. Para as amostras à base de alumina foram utilizados os aditivos poliméricos PMHS, PMS (polimetilsilsesquioxano) e PPS (polifenihnetilvinilhidrogenosilsesquioxano) e as sinterizações foram realizadas a 1650 °C e 1700 °C, não havendo variações significativas nas densidades obtidas nas duas temperaturas. Nos materiais com adição de PMHS foram obtidos compósitos de alumina e mulita, sendo que os grãos de mulita foram formados intergranularmente. Nas amostras contendo PMS ou PPS a distribuição das feses formadas, Si2Al4O4N4 e Si2ON2, foi bastante heterogênea, A obtenção de compósitos cerâmicos utilizando pequenas adições de polímeros precursores cerâmicos mostrou-se viável para materiais à base de alumina, sendo uma rota simples de conformação, com grande potencial para a obtenção de peças com geometria complexa. / The effects of the addition of precursor polymers on sintering, microstructure, hardness and fiacture toughness of silicon carbide and alimiina ceramics were studied. The ceramic raw materials were characterized by semi-quantitative analysis by X-ray fluorescence, particle size by laser diffraction, specific surface area by gas adsorption and microstructural analysis by scanning elecfron microscopy. The polymers were analyzed by thermogravimetry. The sintering kinetics of cold-pressed specimens was studied by dilatometry. The sintered materials were characterized by evaluation of apparent density by the Archimedes technique and/or helium picnometry, by mercury porosimetry, by X-ray diflftaction, by evaluation of total carbon content, by scanning and transmission electron microscopy, by enetgy dispersion X-ray spectrometry, and by Vickers indentation analysis for determining hardness and fiacture toughness. AI2O3 (4wt.%) and Y2O3 (4wt.%) and polymetylhydrogenosiloxane and polymetylhydrogenossiloxane with D4Vi were the sintering aids for SiC. The processing procedures were material cure, pyrolysis and sintering (1850 X and 1950 °C/1 h, Ar or N2). High mass loss was measured in silicon carbide based ceramics, mainly under argon. Silicon carbide based ceramics with polymer sintering aids achieved 3.15 g/cm3 density after pyrolysis at 900 °C under N2 and sintering at 1950 °C under nitrogen. PMHS, PMS and PPS polymer sintering aids were used for almnina based ceramics sintering carried out at 1650 °C and 1700 °C, without significant difference in the final density. Addition of PMHS yielded alumina and mullite composites, with intergranular mullite grains. Heterogeneous Si2AI4O4N4 and Si2ON2 phases were obtained in specimens with PMS or PPS, The preparation of ceramic composites using small amounts of precursor polymers showed a suitable process for alumina-based ceramics, a simple forming route, with high potential for the fabrication of complex shape pieces.

A doença de Alzheimer (DA) é uma doença neurodegenerativa e a principal causa de demência em idosos. Os mecanismos fisiopatológicos mais envolvidos na DA são: o acúmulo do peptídeo beta amiloide (A?) em agregados extracelulares, e a formação dos emaranhados neurofibrilares (ENF). A Proteína Precursora do Amiloide (APP) é clivada pelas secretases alfa (ADAM10), beta (BACE1) e y (Presenilina 1 [PSEN1]). As plaquetas contêm 95% da APP circulante e possuem toda a maquinaria necessária para estudar perifericamente a APP e suas secretases. A pesquisa de biomarcadores na DA tem como objetivo identificar, em vida, os indicadores do processo patogênico em fluídos corporais e/ou por métodos de imagem cerebral. O objetivo do presente estudo foi investigar proteínas envolvidas no metabolismo da APP em plaquetas de pacientes com DA e o potencial de modificação destas vias pela ação do tratamento com cloridrato de donepezila. Para tanto foram analisadas amostras de 23 pacientes com DA leve ou moderada, avaliados antes e depois de 6 meses de tratamento e 38 indivíduos idosos cognitivamente saudáveis (controles). As variáveis de desfecho estudadas foram: (1) expressão protéica de ADAM10, BACE1 e PSEN1; (2) expressão protéica dos metabólitos secretados da APP de 110 e 130kDa, possibilitando o cálculo da razão de APP (rAPP); e (3) atividade enzimática das APP-secretases ADAM10 e BACE1. Foram utilizados os métodos de western blotting e o fluorimétrico. Encontramos, nos pacientes com DA pré-tratamento, uma diminuição da rAPP em relação aos controles; porém, não identificamos diferenças após seis meses de tratamento. Os níveis de ADAM10 mostraram-se menores em pacientes com DA na avaliação basal quando comparados aos controles, mas também sem modificação com o tratamento, o tratamento mostrou-se associado a uma redução da expressão de BACE1 em pacientes com DA, embora não tenhamos encontrado diferenças entre pacientes e controles na avaliação basal. A expressão de PSEN1 mostrou-se menor nos pacientes com DA pré-tratamento quando comparada aos controles, sem contudo haver alteração em resposta ao tratamento. Quanto à atividade enzimática de ADAM10 e BACE1, não observamos diferenças nos valores pré e pós-tratamento. Nossos achados reforçam a utilidade da utilização de plaquetas como matriz biológica para o estudo do metabolismo da APP em tecidos periféricos e para a investigação de efeitos modificadores da patogenia da DA a partir do tratamento com drogas antidemência / Alzheimer\'s disease (AD) is a neurodegenerative disease and the major cause of dementia in the elderly. The main mechanisms in AD are: extracellular aggregates of beta amyloid peptide (Abeta) and neurofibrillary tangles formation (NFT). Amyloid Precursor Protein (APP) is cleaved by the secretases alfa (ADAM10), beta (BACE1) and ? (Presenilin 1 [PSEN1]). Platelets containing 95% of the circulating APP and possess all the machinery necessary to study peripherically APP and its secretases. The search for biomarkers in AD aims to identify, in life, the pathogenic process indicators in body fluids and/or brain image methods. The aim of this study was to investigate proteins involved in APP metabolism in platelets of AD patients, and the potential modification of these pathways by treatment with Donepezil hydrochloride. Therefore, 23 patients with mild to moderate AD evaluated before and after 6 months treatment and 38 healthy elderly subjects (controls) were analyzed. Outcome variables were: (1) ADAM10, BACE1 and PSEN1 expression; (2) APP secreted metabolites expression (110 and 130kDa), allowing the APP ratio (rAPP) estimate; (3) APP-secretase ADAM10 and BACE1 enzymatic activity. Western blotting and fluorimetric methods were used. We found in AD patients pre-treatment, a decrease of rAPP compared to controls; however, we did not identify differences of this parameter after six months of treatment. The ADAM10 levels were lower in AD patients at baseline when compared to controls, however no differences were observed after treatment. Treatment was associated with a reduction of BACE1 expression in AD patients, although we have not found differences between patients and controls at baseline. PSEN1 expression was lower in pre-treatment AD patients compared to controls. No differences were observed after treatment. Concerning to BACE1 and ADAM10 enzymatic activity, we did not observe differences in pre and post-treatment. Our findings strengthen the use of platelets as a biological matrix for the APP metabolism as well as the modifying effects on AD pathogenicity of antidementia drugs

Submitted by Erika Demachki (erikademachki@gmail.com) on 2015-02-06T19:10:57Z No. of bitstreams: 2 Dissertação - Glenda Máris Mesquita - 2014.pdf: 2853247 bytes, checksum: 9d2a3ce805d17ee8a52d5b6e670276af (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) / Rejected by Erika Demachki (erikademachki@gmail.com), reason: on 2015-02-06T19:11:34Z (GMT) / Submitted by Erika Demachki (erikademachki@gmail.com) on 2015-02-06T19:12:05Z No. of bitstreams: 2 Dissertação - Kellen Cristina Mesquita Borges - 2014.pdf: 3970061 bytes, checksum: 15aea92006b36cf4ed11f31faf3f0e62 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) / Approved for entry into archive by Erika Demachki (erikademachki@gmail.com) on 2015-02-06T19:12:23Z (GMT) No. of bitstreams: 2 Dissertação - Kellen Cristina Mesquita Borges - 2014.pdf: 3970061 bytes, checksum: 15aea92006b36cf4ed11f31faf3f0e62 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) / Made available in DSpace on 2015-02-06T19:12:23Z (GMT). No. of bitstreams: 2 Dissertação - Kellen Cristina Mesquita Borges - 2014.pdf: 3970061 bytes, checksum: 15aea92006b36cf4ed11f31faf3f0e62 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) Previous issue date: 2014-04-11 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES / The study of the synthesis of materials which have proton conductivity contributes to the production of solid electrolytes protonic conductors, used extensively in the operation of fuel cells. Materials doped barium zirconate yttrium (BZYO) and barium cerate doped with gadolinium (BCGO), were synthesized by the polymeric precursor method, which stands as an effective technique. The synthesized powders were characterized by thermal analysis (TG-DTA), X-ray Diffraction (XRD), Scanning Electron Microscopy (SEM / FEG) and Zeta Potential. The sinterability of the powders was observed by dilatometric analysis, followed by XRD, SEM / FEG and density apparent. From the results obtained it was possible to verify the formation of BZYO phase at a temperature of 900 °C/ 2h. A higher dopant concentration (20% Y) promoted the formation of the phase in a temperature 800 °C/ 2h, and the formation of the phase BCGO at 950 °C/ 2h. The crystallite size calculated by Scherrer's equation, ranged from 20,8 to 15,2 nm and 38,2 to 30,5 nm for BZYO and BCGO respectively. This results depends on the amount of dopant and its capacity to form solid solution. The micrographs (SEM/FEG) confirmed the nanometric nature of the material with a spherical morphology. The zeta potential was -23,6 mV and -22,8 mV for BZYO and BCGO, respectively, which demonstrates a good stability in the formation of colloidal dispersions for thin film formation which are of interest for fuel cells. The pads BCGO showed a satisfactory densification (95,1%) at 1550 °C/ 4h, a result that shows its applicability as proton conductive solid electrolyte. For tablets BZYO the densification was lower than BCGO with a result of bulk density of 73,8% at 1600 °C/ 4h. This result shows the need for heat treatment at higher temperatures to obtain a higher densification of the pellets. / O estudo da síntese de materiais que apresentam condutividade protônica contribui para a produção de eletrólitos sólidos condutores protônicos, bastante utilizados no funcionamento das células a combustíveis. Os materiais de zirconato de bário dopado com ítrio (BZYO) e cerato de bário dopado com gadolínio (BCGO), foram sintetizados pelo método precursor polimérico, que se destaca como uma técnica eficaz. Os pós sintetizados foram caracterizados por Análise Térmica (TG-DTA), Difração de raios-X (DRX), Microscopia Eletrônica de Varredura (MEV/FEG) e Potencial Zeta. A sinterabilidade dos pós foi verificada por análise dilatométrica, seguida das análises de DRX, MEV/FEG e densidade aparente. Através dos resultados obtidos foi possível verificar a formação da fase de BZYO em uma temperatura de 900 ºC/ 2h. Uma maior concentração de dopante (20% Y) promoveu a formação da fase em uma temperatura inferior, 800 ºC/2h, e a formação da fase de BCGO em 950 ºC/2h. O tamanho médio de cristalito, calculado pela equação de Scherrer, variou de 20,8 a 15,2 nm e 38,2 a 30,5 nm para o BZYO e BCGO, respectivamente. Esse resultado dependente da quantidade de dopante e da sua capacidade de formar solução sólida. As micrografias de MEV/FEG confirmaram a natureza nanométrica do material com morfologia do tipo esférica. O potencial zeta foi de -23,6 mV e -22,8 mV para o BZYO e BCGO, respectivamente, o que demostra uma boa estabilidade na formação de dispersões coloidais para formação de filmes finos, que são de interesse para células a combustíveis. As pastilhas de BCGO apresentaram uma satisfatória densificação (95,1%) a 1550 ºC/4 h, resultado este que apresenta sua aplicabilidade como eletrólito sólido condutor protônico. Para as pastilhas do BZYO a densificação foi inferior ao BCGO, com resultado de densidade aparente de 73,8% a 1600 ºC/ 4h. Este resultado mostra a necessidade de um tratamento térmico em temperaturas superiores para obtenção de uma maior densificação das pastilhas.

A doença de Alzheimer (DA) é uma doença neurodegenerativa e a principal causa de demência em idosos. Os mecanismos fisiopatológicos mais envolvidos na DA são: o acúmulo do peptídeo beta amiloide (A?) em agregados extracelulares, e a formação dos emaranhados neurofibrilares (ENF). A Proteína Precursora do Amiloide (APP) é clivada pelas secretases alfa (ADAM10), beta (BACE1) e y (Presenilina 1 [PSEN1]). As plaquetas contêm 95% da APP circulante e possuem toda a maquinaria necessária para estudar perifericamente a APP e suas secretases. A pesquisa de biomarcadores na DA tem como objetivo identificar, em vida, os indicadores do processo patogênico em fluídos corporais e/ou por métodos de imagem cerebral. O objetivo do presente estudo foi investigar proteínas envolvidas no metabolismo da APP em plaquetas de pacientes com DA e o potencial de modificação destas vias pela ação do tratamento com cloridrato de donepezila. Para tanto foram analisadas amostras de 23 pacientes com DA leve ou moderada, avaliados antes e depois de 6 meses de tratamento e 38 indivíduos idosos cognitivamente saudáveis (controles). As variáveis de desfecho estudadas foram: (1) expressão protéica de ADAM10, BACE1 e PSEN1; (2) expressão protéica dos metabólitos secretados da APP de 110 e 130kDa, possibilitando o cálculo da razão de APP (rAPP); e (3) atividade enzimática das APP-secretases ADAM10 e BACE1. Foram utilizados os métodos de western blotting e o fluorimétrico. Encontramos, nos pacientes com DA pré-tratamento, uma diminuição da rAPP em relação aos controles; porém, não identificamos diferenças após seis meses de tratamento. Os níveis de ADAM10 mostraram-se menores em pacientes com DA na avaliação basal quando comparados aos controles, mas também sem modificação com o tratamento, o tratamento mostrou-se associado a uma redução da expressão de BACE1 em pacientes com DA, embora não tenhamos encontrado diferenças entre pacientes e controles na avaliação basal. A expressão de PSEN1 mostrou-se menor nos pacientes com DA pré-tratamento quando comparada aos controles, sem contudo haver alteração em resposta ao tratamento. Quanto à atividade enzimática de ADAM10 e BACE1, não observamos diferenças nos valores pré e pós-tratamento. Nossos achados reforçam a utilidade da utilização de plaquetas como matriz biológica para o estudo do metabolismo da APP em tecidos periféricos e para a investigação de efeitos modificadores da patogenia da DA a partir do tratamento com drogas antidemência / Alzheimer\'s disease (AD) is a neurodegenerative disease and the major cause of dementia in the elderly. The main mechanisms in AD are: extracellular aggregates of beta amyloid peptide (Abeta) and neurofibrillary tangles formation (NFT). Amyloid Precursor Protein (APP) is cleaved by the secretases alfa (ADAM10), beta (BACE1) and ? (Presenilin 1 [PSEN1]). Platelets containing 95% of the circulating APP and possess all the machinery necessary to study peripherically APP and its secretases. The search for biomarkers in AD aims to identify, in life, the pathogenic process indicators in body fluids and/or brain image methods. The aim of this study was to investigate proteins involved in APP metabolism in platelets of AD patients, and the potential modification of these pathways by treatment with Donepezil hydrochloride. Therefore, 23 patients with mild to moderate AD evaluated before and after 6 months treatment and 38 healthy elderly subjects (controls) were analyzed. Outcome variables were: (1) ADAM10, BACE1 and PSEN1 expression; (2) APP secreted metabolites expression (110 and 130kDa), allowing the APP ratio (rAPP) estimate; (3) APP-secretase ADAM10 and BACE1 enzymatic activity. Western blotting and fluorimetric methods were used. We found in AD patients pre-treatment, a decrease of rAPP compared to controls; however, we did not identify differences of this parameter after six months of treatment. The ADAM10 levels were lower in AD patients at baseline when compared to controls, however no differences were observed after treatment. Treatment was associated with a reduction of BACE1 expression in AD patients, although we have not found differences between patients and controls at baseline. PSEN1 expression was lower in pre-treatment AD patients compared to controls. No differences were observed after treatment. Concerning to BACE1 and ADAM10 enzymatic activity, we did not observe differences in pre and post-treatment. Our findings strengthen the use of platelets as a biological matrix for the APP metabolism as well as the modifying effects on AD pathogenicity of antidementia drugs

Doctor of Philosophy(PhD) / This body of research uses numerical and experimental investigative techniques to further the understanding of autoignition. Hydrogen/nitrogen and methane/air fuel configurations of turbulent lifted flames in a vitiated coflow burner are used as model flames for this investigation. Characterisation was undertaken to understand the impact of controlling parameters and the overall behaviour of the flames, and to provide a body of data for modelling comparisons. Modelling of the flames was conducted using the PDF-RANS technique with detailed chemistry incorporated using In-situ Adaptive Tabulation (ISAT) within the commercial CFD package, FLUENT 6.2. From these investigations, two numerical indicators for autoignition were developed: convection-reaction balance in the species transport budget at the mean flame base; and the build-up of ignition precursors prior to key ignition species. These indicators were tested in well defined autoignition and premixed flame cases, and subsequently used with the calculated turbulent lifted flames to identify if these are stabilised through autoignition. Based on learnings from the modelling, a quantitative, high-resolution simultaneous imaging experiment was designed to investigate the correlations of an ignition precursor (formaldehyde: CH2O) with a key flame radical (OH) and temperature. Rayleigh scattering was used to measure temperature, while Laser Induced Fluorescence (LIF) was used to measure OH and CH2O concentrations. The high resolution in the Rayleigh imaging permitted the extraction of temperature gradient data, and the product of the OH and CH2O images was shown to be a valid and useful proxy for peak heat release rate in autoigniting and transient flames. The experimental data confirmed the presence of formaldehyde as a precursor for autoignition in methane flames and led to the identification of other indicators. Sequenced images of CH2O, OH and temperature show clearly that formaldehyde exists before OH and peaks when autoignition occurs, as confirmed by images of heat release. The CH2O peaks decrease later while those of OH remain almost unchanged in the reaction zone.

<p>Alzheimer’s disease (AD) is a progressive neurodegenerative disorder, neuropathologically characterized by neurofibrillay tangles and deposition of amyloid-β (Aβ) peptides. Several mutations in the gene for amyloid precursor protein (APP) cause familial AD and affect APP processing leading to increased levels of Aβ42. However, the Arctic Alzheimer mutation (APP E693G) reduces Aβ levels. Instead, the increased tendency of Arctic Aβ peptides to form Aβ protofibrils is thought to contribute to the pathogenesis. </p><p>In this thesis, the pathogenic mechanisms of the Arctic mutation were further investigated, specifically addressing if and how the mutation affects APP processing. Evidence of a shift towards β-secretase cleavage of Arctic APP was demonstrated. Arctic APP did not appear to be an inferior substrate for α-secretase, but the availability of Arctic APP for α-secretase cleavage was reduced, with diminished levels of cell surface APP in Arctic cells. Interestingly, administration of the fatty acid docosahexaenoic acid (DHA) stimulated α-secretase cleavage and partly reversed the effects of the Arctic mutation on APP processing.</p><p>In contrast to previous findings, the Arctic mutation generated enhanced total Aβ levels suggesting increased Aβ production. Importantly, this thesis illustrates and explains why measures of both Arctic and wild type Aβ levels are highly dependent upon the Aβ assay used, with enzyme-linked immunosorbent assay (ELISA) and Western blot generating different results. It was shown that these differences were due to inefficient detection of Aβ oligomers by ELISA leading to an underestimation of total Aβ levels. </p><p>In conclusion, the Arctic APP mutation leads to AD by multiple mechanisms. It facilitates protofibril formation, but it also alters trafficking and processing of APP which leads to increased steady state levels of total Aβ, in particular at intracellular locations. Importantly, these studies highlight mechanisms, other than enhanced production of Aβ peptide monomers, which could be implicated in sporadic AD.</p>

Hyperthermia damages both developing and adult brains, especially when it occurs after ischemia or stroke. Work presented in this dissertation used in vitro models of these stresses to investigate mechanisms underlying damage to immature neurons and neural precursors cultured from embryonic rat brain. Studies described in Chapter 2 investigated the effects of a brief, intense hyperthermic stress (30-45 min at 43ºC). This stress produced a selective depletion of nestin-immunoreactive neural precursor cells, and reduced proliferation, as evidenced by reduced BrdU incorporation into young Tuj1-immunoreactive neurons. The stress activated caspase 3, and produced multiple signs of nuclear damage as well as early and persisting mitochondrial depolarization. Cycloheximide, an inhibitor of protein synthesis, reduced cell death. All these findings suggest an apoptotic death process. Studies described in Chapter 3 used a combination of oxygen-glucose deprivation (OGD, 2 h) followed by mild 41ºC hyperthermia for 90 min (T). The combined OGDT stress reduced both survival in monolayer cultures and colony-forming ability in neurospheres. Cell death occurred gradually over 2 days, and was accompanied by caspase activation that began within 6 h post-stress. Post-stress application of cycloheximide or a general caspase inhibitor (especially qVD-OPH) reduced cell death, but specific inhibitors of caspases 2, 3, 8 or 9 were ineffective. OGDT led to upregulation of the pro-apoptotic protein Bim as well as redistribution of Bax from cytoplasm to mitochondria within 6 h. Persisting mitochondrial depolarization began within 3 h following the combined OGDT stress, but not following individual OGD or T stresses alone. These findings suggest that OGD sensitizes neural precursor cells to hyperthermia-induced damage, and that the combined OGDT stress kills neural precursors via apoptotic mechanisms that include activation of mitochondrial death pathways. Results of these studies suggest that immature neurons and neural precursors are especially vulnerable to hyperthermia-induced damage via apoptotic mechanisms. Pan-caspase inhibitors may be a promising therapeutic strategy to preserve viability of these cells following stroke with hyperthermia.

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder, neuropathologically characterized by neurofibrillay tangles and deposition of amyloid-β (Aβ) peptides. Several mutations in the gene for amyloid precursor protein (APP) cause familial AD and affect APP processing leading to increased levels of Aβ42. However, the Arctic Alzheimer mutation (APP E693G) reduces Aβ levels. Instead, the increased tendency of Arctic Aβ peptides to form Aβ protofibrils is thought to contribute to the pathogenesis. In this thesis, the pathogenic mechanisms of the Arctic mutation were further investigated, specifically addressing if and how the mutation affects APP processing. Evidence of a shift towards β-secretase cleavage of Arctic APP was demonstrated. Arctic APP did not appear to be an inferior substrate for α-secretase, but the availability of Arctic APP for α-secretase cleavage was reduced, with diminished levels of cell surface APP in Arctic cells. Interestingly, administration of the fatty acid docosahexaenoic acid (DHA) stimulated α-secretase cleavage and partly reversed the effects of the Arctic mutation on APP processing. In contrast to previous findings, the Arctic mutation generated enhanced total Aβ levels suggesting increased Aβ production. Importantly, this thesis illustrates and explains why measures of both Arctic and wild type Aβ levels are highly dependent upon the Aβ assay used, with enzyme-linked immunosorbent assay (ELISA) and Western blot generating different results. It was shown that these differences were due to inefficient detection of Aβ oligomers by ELISA leading to an underestimation of total Aβ levels. In conclusion, the Arctic APP mutation leads to AD by multiple mechanisms. It facilitates protofibril formation, but it also alters trafficking and processing of APP which leads to increased steady state levels of total Aβ, in particular at intracellular locations. Importantly, these studies highlight mechanisms, other than enhanced production of Aβ peptide monomers, which could be implicated in sporadic AD.

Double layer capacitors owe their large capacitance to high specific surface area carbon-based electrode materials adhered to a current collector via an adhesive. However, recent studies attribute greater electrical energy storage capacity to transition metal oxides/nitrides: a new generation of electrode materials for use in super-capacitors with mixed double-layer and pseudo-capacitive properties. Solution precursor plasma spray deposition is a technique that allows coatings to be fabricated with fine grain sizes, high porosity levels, and high surface area; characteristics ideal for application as super-capacitor electrodes. This investigation established conditions for deposition of porous, high specific surface area α-MoO3. It further identified a two-step temperature-programmed reaction for topotactic phase transformation of the α-MoO3 deposits into high specific surface area molybdenum nitrides of higher conductivity and higher electrochemical stability window. The electrochemical behavior of molybdenum oxide/nitride deposits was also studied in order to assess their potential for use in super-capacitors.

Double layer capacitors owe their large capacitance to high specific surface area carbon-based electrode materials adhered to a current collector via an adhesive. However, recent studies attribute greater electrical energy storage capacity to transition metal oxides/nitrides: a new generation of electrode materials for use in super-capacitors with mixed double-layer and pseudo-capacitive properties. Solution precursor plasma spray deposition is a technique that allows coatings to be fabricated with fine grain sizes, high porosity levels, and high surface area; characteristics ideal for application as super-capacitor electrodes. This investigation established conditions for deposition of porous, high specific surface area α-MoO3. It further identified a two-step temperature-programmed reaction for topotactic phase transformation of the α-MoO3 deposits into high specific surface area molybdenum nitrides of higher conductivity and higher electrochemical stability window. The electrochemical behavior of molybdenum oxide/nitride deposits was also studied in order to assess their potential for use in super-capacitors.